MedPath

EVOTAZ

EVOTAZ

Discontinued
DIN Number

02446731

Drug Class

Human

Market Date

Feb 11, 2016

Company
HC

bristol-myers squibb canada

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02446731
AIG Number0257430001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AR15 ATANAZAVIR AND COBICISTAT
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification92:92.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

ATAZANAVIR (ATAZANAVIR SULFATE)Active
Strength: 300 MG
Monograph: ATAZANAVIR (ATAZANAVIR SULFATE)
COBICISTATActive
Strength: 150 MG
Monograph: COBICISTAT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.